First, bisulfite sequencing analyses of an amplicon encompassing the entire predicted ACSL3 5′-CGI (Figure 4A, BSPCR marks the amplicon) were performed on the 20 UWBC DNA samples; five from each of the high or low PAH groups with or without asthma. This evidence concerns the gene ACSL3 and pulmonary arterial hypertension.